Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074438
Status:
COMPLETED
Last Update Posted:
2013-05-09
First Post:
2003-12-12
Brief Title:
Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
Randomized Multifactorial Double-blind Parallel-group Dose-ranging Study of the Efficacy and Safety of Rituximab MabTheraRituxan in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the efficacy and safety of different treatment regimens of rituximab MabTheraRituxan corticosteroids and placebo combined with methotrexate MTX in patients with active rheumatoid arthritis RA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| WA17043 | None | None | None |